Jane Kiernan

Track

Insider profile

Currently holds positions in Axonics Modulation Technologies Inc and Endologix Inc

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Axonics Modulation Technologies Inc April 8, 2019 -
Independent Director Endologix Inc March 12, 2020 -
Jane Kiernan's trades of Treace Medical Concepts Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-14 2024-05-14
B Purchase
30,180 +5.5%
195.59
US$346,552 		30,180 +5.5% 195.59 US$346,552
2022-07-07 2022-07-05
PlS Planned sale
60,464 -4.7%
259.13
US$738,496 		60,464 -4.7% 259.13 US$738,496
2022-07-07 2022-04-01
PlS Planned sale
54,870 -4.0%
246.57
US$2,312,165 		54,870 -4.0% 246.57 US$2,312,165